2005
DOI: 10.1242/jcs.02382
|View full text |Cite
|
Sign up to set email alerts
|

Alix regulates cortical actin and the spatial distribution of endosomes

Abstract: Alix/AIP1 is a proline-rich protein that has been implicated in apoptosis, endocytic membrane trafficking and viral budding. To further elucidate the functions of Alix, we used RNA interference to specifically suppress its expression. Depletion of Alix caused a striking redistribution of early endosomes from a peripheral to a perinuclear location. The redistribution of endosomes did not affect transferrin recycling or degradation of endocytosed epidermal growth factor receptors, although the uptake of transfer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

11
102
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(113 citation statements)
references
References 59 publications
11
102
0
Order By: Relevance
“…These multitasking properties of Alix derive from the ability of the protein to interact with a plethora of partner proteins, which are themselves components of large oligomeric complexes. By interacting with the endosomal sorting complexes required for transport, ESCRT I and III, Alix synergistically coordinates endocytosis and recycling of mem-brane receptors, viral budding, and cytokinesis (13)(14)(15)(16)(17)(18)(19)(20). Relevant to this study are the findings that Alix also participates in cytoskeleton remodeling by binding with F-actin, ␣-actinin, cortactin, and focal adhesion kinase (14,21).…”
mentioning
confidence: 76%
See 1 more Smart Citation
“…These multitasking properties of Alix derive from the ability of the protein to interact with a plethora of partner proteins, which are themselves components of large oligomeric complexes. By interacting with the endosomal sorting complexes required for transport, ESCRT I and III, Alix synergistically coordinates endocytosis and recycling of mem-brane receptors, viral budding, and cytokinesis (13)(14)(15)(16)(17)(18)(19)(20). Relevant to this study are the findings that Alix also participates in cytoskeleton remodeling by binding with F-actin, ␣-actinin, cortactin, and focal adhesion kinase (14,21).…”
mentioning
confidence: 76%
“…More recent reports have implicated Alix in other basic cellular processes, which all hinge on membrane trafficking, endosomal sorting, and remodeling of the actin cytoskeleton (12)(13)(14). These multitasking properties of Alix derive from the ability of the protein to interact with a plethora of partner proteins, which are themselves components of large oligomeric complexes.…”
mentioning
confidence: 99%
“…An alternative explanation comes from the observations that multivesicular endosomes contain more than one type of lumenal vesicles (Gillooly et al, 2000;Kobayashi et al, 2002;Sobo et al, 2007a), raising the possibility that some are involved in the transport of signaling receptors to the lysosomes, whereas others undergo fusion at the limiting membrane. If so, intralumenal mechanisms must control the fate of intralumenal vesicles, back-fusion or degradation, including perhaps LBPA via its effector Alix, because Alix knockdown inhibits back-fusion (Abrami et al, 2004;Le Blanc et al, 2005) but not EGF receptor degradation (Schmidt et al, 2004;Cabezas et al, 2005). In addition, it cannot be excluded that some signaling receptors are returned to the endosomelimiting membrane via back-fusion and then recaptured within newly formed vesicles, perhaps like the EGF receptor in our assay, a mechanism that may contribute to explain MAPK signaling from late endosomes (Teis et al, 2002;Taub et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…In trafficking events, cortactin has been involved in clathrin-mediated endocyto-sis as well as in pinocytosis, regulation of epidermal growth factor receptor (EGFR) degradation, or endosomal positioning (McNiven et al, 2000;Cao et al, 2003Cao et al, , 2005Lynch et al, 2003;Cabezas et al, 2005;Merrifield et al, 2005;Sauvonnet et al, 2005;Timpson et al, 2005;Zhu et al, 2005;Mettlen et al, 2006;Le Clainche et al, 2007).…”
Section: Introductionmentioning
confidence: 99%